Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Incyte

FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD

FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD

Submission is based on results from the pivotal REACH3 study. The US Food and Drug Administration (FDA) has awarded Incyte’s Jakafi a priority review for the treatment of steroid-refractory ... A decision on the JAK1/2 inhibitor is expected by 22 June

Regeneron’s COVID-19 antibody cocktail scores FDA emergency approval

Regeneron’s COVID-19 antibody cocktail scores FDA emergency approval Last week, Eli Lilly and Incyte’s repurposed arthritis treatment baricitinib also scored an EUA in combination with Gilead’s remdesivir for the treatment of hospitalised COVID-19 patients.

Lilly’s repurposed COVID-19 med baricitinib bags FDA emergency approval

Lilly’s repurposed COVID-19 med baricitinib bags FDA emergency approval Drug approved for emergency use in combination with Gilead's remdesivir. Eli Lilly and Incyte’s arthritis treatment baricitinib has been repurposed as a COVID-19 treatment, scoring an emergency use

Switzerland: a life sciences hub

Switzerland: a life sciences hub American oncology specialist Incyte invested $100m for a monoclonal antibody production site in Yverdon (Vaud).

Incyte launches award programme recognising innovation in GVHD community

Incyte launches award programme recognising innovation in GVHD community have a devastating impact on the lives of patients,” said Barry Flannelly, executive vice president and general manager, US, Incyte. ... Through the Incyte Ingenuity Award, we hope to spark creativity and innovation, which we expect to result in

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...